Mergermarket Private Equity Forum - Chicago | 1 June 2024 | TBA, Chicago

Advance your strategic capital allocation journey with this event, the second in our four-part US Private Equity series. This year, we're pivoting from our previous M&A focus to delve deeper into the realm of private equity, equipping fund managers, institutional investors, and M&A professionals with the insights, tools, and connections necessary to navigate the complexities of private equity dealmaking.

Building on the success of last year's M&A-focused event, the Chicago forum is evolving to meet the needs of its diverse attendees in the private equity space. If you're an LP, seize this opportunity to interact with peers, keep abreast of GPs' tactics for addressing pressing concerns, and scout for prospective GPs to enrich your portfolio. For GPs, the event presents an opportunity to connect with potential investors and showcase your distinctive investment strategies. M&A professionals will find this occasion invaluable for networking with key industry players and fostering connections that could lead to future collaborations.

Powered by next-generation Mergermarket, we offer a distinct advantage that sets us apart from other industry events. Our proprietary private equity and M&A intelligence, coupled with our AI-driven predictive analytics, forms the foundation of the forum, delivering a wealth of data and insights that are unparalleled in the industry.

Why should I attend?
Strategic Insights:
• Gain a competitive edge with actionable insights from expert LPs and GPs in the region. Get an inside look at their capital allocation plans and distinctive investment strategies. Armed with this expert knowledge, you'll be better equipped to make informed decisions and stay ahead in this rapidly changing market.

Professional Growth:
• Empower your professional development in the private equity domain. Participate in thought-provoking discussions led by industry veterans. Whether you're an experienced professional or just embarking on your private equity journey, you'll walk away with enhanced skills and fresh perspectives to drive success in your organization.

Networking:
• Enhance your professional network by engaging with prominent LPs, GPs, and M&A advisors during our networking sessions. Exchange ideas, form potential collaborations, and identify prospective partners, setting the stage for future business opportunities. Seize this chance to strengthen your network and achieve success.

2023 Past Speakers

Josh Armstrong
Deputy Managing Editor, Mergermarket

Elizabeth Browne
Managing Director, Gcm Grosvenor

Richard Buchband
Senior Vice President and Chief Legal Officer, Manpowergroup

Thomas Chadwick
Principal, Pritzker Private Capital

David R. Clark
Partner, Skadden

Clint Coghill
Head of Investors, Ion Analytics

Marc Cooper
Chief Executive Officer, Solomon Partners

Steven M. Dresner
Founder and President, Dresner Partners

Warren Estey
Head, U.S. Mergers & Acquisitions Group, Bmo Capital Markets

Michael Fein
Founder and Ceo, Campaign Management

Dayna Fields
Senior M&a Reporter, Mergermarket

Alex Friedman
Principal - Business Development, Periscope Equity

Andrey Galiuk
Vice President, Corporate Development & Investor Relations, Dover Corporation

Jessica Harger
Managing Director, Aon

Ellen Havdala
Managing Director, Equity Group Investments

Andy He
Managing Director, Alixpartners

Duncan Herrington
Managing Director, Shareholder Advisory, Moelis

Erik Levy
Group Head Corporate Development and M&a, Dmgt

Stephen Marks
Managing Director, Emmersion Capital

Carlos Martinez
Canada Editor, Mergermarket

Raquel Mozzer
Head of Data, Mergermarket

Vip Patel
Managing Director, Aon

Nick Potter
Principal, Financial Services, the Vistria Group

Robert Rosenfeld
Managing Director, Consumer, Robert W. Baird & Co.

William Rowe
Partner, Baker Mckenzie

Kelly Scheltens
Director, Mergers & Acquisitions, Crowley

Dan Scorpio
Managing Director, Head of M&a and Activism, H/advisors Abernathy

Rachel Stone
Charlottesville Bureau Chief, Mergermarket

Rachel Strick
Head of Immunology Business Development & Acquisitions, Abbvie

Kimberly Trautmann
Head, Drw Venture Capital

Philip Whitchelo
Chief Marketing & Strategy Officer, Sterling Technology